Income Statement | | | | | | | | | | | |
| | | | | | | Original | | | | |
USD | | | Latest | | Year-to-date Ending | |
(in millions) | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | | Sep-24 | | Sep-23 | Sep-24 | |
| FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM | | YTD-1 | YTD | |
| | | | | | | | | | | |
Net Revenue | 6 | 6 | 5 | 7 | 5 | | 6 | | 5 | 6 | |
% Growth | NA | -6.5% | -5.9% | 32.3% | -30.6% | | | | | 23.9% | |
| | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | 0 | |
Selling and Marketing | (0) | (0) | (0) | (0) | (0) | | (0) | | (0) | (0) | |
General and Admin | (5) | (6) | (5) | (6) | (7) | | (8) | | (5) | (6) | |
Other Exp / (Inc) | (1) | (1) | (1) | (1) | (1) | | (1) | | (1) | (1) | |
Total Operating Exp | (6) | (6) | (6) | (7) | (8) | | (10) | | (5) | (7) | |
| | | | | | | | | | | |
Operating Income | 0 | (1) | (0) | 0 | (3) | | (3) | | (0) | (1) | |
% Revenue | 5.4% | -10.9% | -5.0% | 2.5% | -60.4% | | -55.8% | | -5.6% | -11.7% | |
| | | | | | | | | | | |
Interest Expense | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | 0 | |
Pre-tax Income | 0 | (1) | (0) | 0 | (3) | | (3) | | (0) | (1) | |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | 0 | |
Provision for Taxes | 0 | 1 | 0 | (0) | (1) | | (1) | | 0 | 0 | |
Net Income to Company | 0 | (0) | (0) | 0 | (4) | | (5) | | (0) | (1) | |
% Margin | 6.8% | -2.0% | -1.0% | 0.4% | -80.9% | | -73.8% | | -3.7% | -11.7% | |
| | | | | | | | | | | |
Minority Interest in Earnings | | | | | | | 0 | | (0) | 0 | |
Net Income to Stockholders | 0 | (0) | (0) | 0 | (4) | | (5) | | (0) | (1) | |
| | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | 0 | |
Other Adj. | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | 0 | |
| | | | | | | | | | | |
Net Income to Common | 0 | (0) | (0) | 0 | (4) | | (5) | | (0) | (1) | |
% Margin | 6.8% | -2.0% | -1.0% | 0.4% | -80.9% | | -73.8% | | -3.7% | -11.7% | |
| | | | | | | | | | | |
As Reported | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.00 | 0.00 | (0.01) | 0.01 | (0.79) | | (0.90) | | (0.04) | (0.15) | |
Diluted EPS (Continuing Ops) | 0.00 | 0.00 | (0.01) | 0.01 | (0.79) | | (0.90) | | (0.04) | (0.15) | |
| | | | | | | | | | | |
WA Basic Shares Out. | 0 | 0 | 5 | 5 | 5 | | 5 | | 5 | 5 | |
WA Diluted Shares Out. | 0 | 0 | 5 | 5 | 5 | | 5 | | 5 | 5 | |
| | | | | | | | | | | |
Unusual Items Reconciliation | | | | | | | | | | | |
Addback: Other Non Operating Expenses, Total | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | 0 | |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | 0 | |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | 0 | |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | 0 | |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | 0 | |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | 0 | |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | 0 | |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | 0 | |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | | (0) | | 0 | (0) | |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | 0 | |
Addback: Other Unusual Items | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | 0 | |
Total Unusual Items | 0 | 0 | 0 | 0 | 0 | | (0) | | 0 | (0) | |
% Margin | 0.6% | 0.0% | 0.0% | 0.0% | 0.0% | | -1.1% | | 0.0% | -1.1% | |
| | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | |
Net Income to Company | 0 | (0) | (0) | 0 | (4) | | (5) | | (0) | (1) | |
Addback: Unusual Items | 0 | 0 | 0 | 0 | 0 | | (0) | | 0 | (0) | |
Less: Tax Benefit of Unusual Items (26%) | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | 0 | |
Adjusted Net Income | 0 | (0) | (0) | 0 | (4) | | (5) | | (0) | (1) | |
% Margin | 6.8% | -2.0% | -1.0% | 0.4% | -80.9% | | -74.6% | | -3.7% | -12.5% | |
| | | | | | | | | | | |
Adjusted Basic EPS | NA | NA | (0.01) | 0.01 | (0.79) | | (0.93) | | (0.04) | (0.16) | |